ITOC 6-K SEC Filing Analysis

Latest settled — T+5d

ITOC ▼ -2.94% at T+5d

SHORT call ✓ call won +2.94% · α vs SPY +3.85% · entry $0.3740 → $0.3630

Next anchor: T+20d in 12h

Currently $0.2879 · +23.02% from $0.3740 entry (call sign-flipped)

Entry anchored
Apr 23, 04:14 PM ET
via Databento tick

T+1d

+8.29%

call -8.29% · α -8.12%

$0.4050

settled 26d ago

T+5d

-2.94%

call +2.94% · α +3.85%

$0.3630

settled 20d ago

T+20d

—

call — · α —

—

in 12h

T+60d

—

call — · α —

—

in 2mo

Price Chart

Loading chart...

Executive Summary

iTonic Holdings Ltd received an 180-day extension from Nasdaq, until October 19, 2026, to regain compliance with the minimum bid price rule after failing to meet it by April 20, 2026. If the stock price does not sustain above $1.00 by the deadline, the company faces delisting.

Actionable Insight

The extension delays but does not resolve the delisting threat. Given the company's weak financial position and prior dilutive financing, traders should anticipate potential further dilution or reverse stock split ahead of October 2026 to avoid delisting. Monitor for upcoming reverse split announcements or capital-raising activities as key catalysts.

Key Facts

Nasdaq granted a 180-day extension, expiring October 19, 2026, for iTonic to regain compliance with the $1.00 minimum bid price requirement.
The initial 180-day compliance period ended April 20, 2026, without the company regaining compliance.
Failure to meet the requirement by October 19, 2026, will result in a delisting notice, though the company may appeal to a Nasdaq Hearings Panel.
This follows a prior 20-F filing that revealed deteriorating financials: net loss widened to $5.1M in 2025 from $660k in 2024, cash reserves dropped from $6.2M to $1.5M, and a recent private placement occurred at a 51.7% discount, signaling distress.

Financial Impact

High risk of delisting and further dilution; no direct financial transaction, but structural risk to equity value is significant.

stock pricemarket capitalizationequity valueinvestor confidence

Risk Factors

Delisting from Nasdaq if the share price remains below $1.00 by October 19, 2026.
Further shareholder dilution or a reverse stock split likely to meet listing requirements, which could pressure trading dynamics.

Market Snapshot

Exchange

Nasdaq

Sector

Electromedical & Electrotherapeutic Apparatus

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

Document	Accession Number
6-K Filing (Primary)	0001213900-26-047086
Document: ea028747201ex99-1.htm	0001213900-26-047086
Document: 0001213900-26-047086-index-headers.html	0001213900-26-047086
Document: 0001213900-26-047086-index.html	0001213900-26-047086
Document: 0001213900-26-047086.txt	0001213900-26-047086

2 reports for ITOC

T+1T+5T+20T+60

Track record builds as more directional reports settle.

Filters

Reports for ITOC — sortable, filterable
	Type				Now
Apr 23, 2026 27d ago	6-K BEARISH ★ 7/10	$0.3740 $0.3630	▲ +2.94%	▲ +3.85%	$0.2879 (+23.02%)
Mar 30, 2026 7w ago	20-F BEARISH ★ 8/10	$0.3500 $0.3110	▲ +11.14%	▲ +15.09%	$0.2879 (+17.74%)

US Market Status

Market Closed — Opens Thu (< 1m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access